IKS Earns Best in KLAS Award for 3rd Consecutive Year

Best-in-KLAS-2021-Transcription-Services

February 2, 2021 – Cary, NC – AQuity Solutions has been recognized by KLAS Research as the 2021 Best in KLAS Transcription Service. This marks the third consecutive year AQuity has been recognized as the top Transcription Service based on random surveys of active clients of competing vendors. KLAS rankings are considered the gold standard in the Health Information Management and Revenue Cycle Management industries for their accurate, honest, and impartial research analytics.


“We’ve made significant investments over the years to ensure quality, security, and customer satisfaction,” noted Regina Buchwald, VP of AQuity’s Transcription Services division. “Especially during COVID, where many industry participants struggled, it is very rewarding to have 100% of our transcription clients affirm they would buy from us again. We see this as validation of our unwavering commitment to the discipline and our ongoing transcription business strategy.”


“KLAS rankings are extremely important to our prospects, to our clients, and to us,” added Michael Daughton, AQuity’s Senior VP of Sales and Marketing. “We understand our clients are under constant pressure to reduce costs and increase value from every support function. Our ability to stay on top while growing the business during such a tumultuous year speaks volumes about our entire team and our commitment to service.”

“Our ability to earn top scores from KLAS depends on our ability to provide stable, secure environments for our exceptional services,” noted Marty Serro, AQuity’s CIO and Security Officer. “AQuity has invested a great deal in our Infrastructure, security, and educational programs continually advancing our security and compliance posture. Those investments ensured complete business continuity through the COVID pandemic. Today’s market expects comprehensive security and compliance with their services. That combination is what drives our success.”


“We put a high priority on our performance across all business units,” added Jason Kolinoski, AQuity’s COO. “Having KLAS affirm 100% of both our Transcription and Coding Service clients would buy from us again is truly rewarding and shows the value of our flexible platform, industry-leading security, mature service processes, and global advantages. We are honored to be considered a trusted partner in our client’s clinical documentation strategy, I would like to thank our wonderful clients and express gratitude to our dedicated employees for the honor of being recognized Best in KLAS.”

About IKS Health

IKS Health takes on the chores of healthcare—spanning administrative, clinical, and operational burdens—so that clinicians can focus on their core tasks of medical care delivery. Combining pragmatic technology and dedicated experts, IKS enables stronger, financially sustainable enterprises. IKS’s Care Enablement Platform delivers data-driven value and expertise across the care journey, and IKS is a partner for clinician enterprises looking to effectively scale, improve quality and achieve cost savings through forward-thinking solutions. Founded in 2006, IKS’s technology-enabled solutions and global workforce supports large health systems, medical groups and risk bearing entities across the United States. For more information, visit ikshealth.com.

Inventurus Knowledge Solutions Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its equity shares, and has filed a draft red herring prospectus (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of SEBI at www.sebi.gov.in as well as on the websites of the book running lead managers, ICICI Securities Limited, JM Financial Limited, J.P. Morgan India Private Limited, Jefferies India Private Limited and Nomura Financial Advisory and Securities (India) Private Limited, at https://www.icicisecurities.com, https://www.jmfl.com/, www.jpmipl.com, www.jefferies.com and www.nomuraholdings.com/company/group/asia/india/index.html respectively, and the websites of the stock exchange(s) at www.nseindia.com and www.bseindia.com, respectively. Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, see “Risk Factors” of the RHP, when available. Potential investors should not rely on the DRHP for any investment decision.

Media Contact – IKS Health
Sarah Bennight
Senior Vice President
sarah.bennight@ikshealth.com

Contact – IKS Health India:
Srushti Rao
VP Communications, IKS Health
+91 98203 94009
srushti.rao@ikshealth.com

Share this post